507
Views
4
CrossRef citations to date
0
Altmetric
Research Article

Association between smoking behavior patterns and chronic obstructive pulmonary disease: A long-term follow-up study among Finnish adults

, , &
Pages 598-606 | Received 13 Dec 2010, Accepted 04 Apr 2011, Published online: 10 Sep 2012

References

  • Global Initiative of Chronic Obstructive Pulmonary Disease (GOLD). Global Strategy for Diagnosis, Management and Prevention of COPD. Updated in 2010. Accessed 11 May 2011.
  • Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence, and future trends. Lancet. 2007;370:765–73.
  • Wan ES, Silverman EK. Genetics of COPD and emphysema. Chest. 2009;136:859–66.
  • Pietinalho A, Kinnula VL, Sovijärvi AR, Vilkman S, Säynäjäkangas O, Liippo K, . Chronic bronchitis and chronic obstructive pulmonary disease. The Finnish Action Programme, interim report. Respir Med. 2007;101:1419–25.
  • Kotaniemi J. Asthma, chronic obstructive pulmonary disease and respiratory symptoms among adults: prevalence and risk factors—The FinEsS Study in Northern Finland [thesis]. Helsinki: University of Helsinki; 2006. Available at: https://oa.doria.fi/bitstream/handle/10024/2032/asthmach.pdf?sequence=1. Accessed 11 May 2011.
  • Lundbäck B, Lindberg A, Lindström M, Rönmark E, Jonsson AC, Jönsson E, . Not 15 but 50% of smokers develop COPD? Report from the Obstructive Lung Disease in Northern Sweden Studies. Respir Med. 2003;97: 115–22.
  • Bjartveit K, Tverdal A. Health consequences of smoking 1-4 cigarettes per day. Tob Control. 2005;14:315–20.
  • Korhonen T, Broms U, Levälahti E, Koskenvuo M, Kaprio J. Characteristics and health consequences of intermittent smoking: Long-term follow-up among Finnish adult twins. Nicotine Tob Res. 2009;11:148–55.
  • Pisinger C, Godtfredsen NS. Is there a health benefit of reduced tobacco consumption? A systematic review. Nicotine Tob Res. 2007;9:631–46.
  • Fagerström, K. Smoking reduction in the management of COPD. Monaldi Arch Chest Dis. 2002;57:281–4.
  • Tashkin DP. Long-acting anticholinergic use in chronic obstructive pulmonary disease: efficacy and safety. Curr Opin Pulm Med. 2010;16:97–105.
  • Gross NJ. Anticholinergic agents in asthma and COPD. Eur J Pharmacol. 2006;533:36–9.
  • Kinnula V, Tukiainen P, Katajisto M, Keistinen T, Tikkanen H, Sovijärvi A. Working group appointed by the Finnish Medical Society Duodecim and the Finnish Respiratory Society. Käypä hoito-suositus: Keuhkoahtaumatauti (English summary: Chronic Obstructive Pulmonary Disease, Diagnosis and Treatment). Updated in 2009. Accessed 11 May 2011.
  • Pauwels R. Global initiative for chronic obstructive lung diseases (GOLD): time to act. Eur Respir J. 2001;18:901–2.
  • Jousilahti P, Komulainen J, Hanski T, Kaila M, Ketola E. Perusterveydenhuollon lääkärit tuntevat hyvin Käypä Hoito-suositukset (English summary: Knowledge of, attitudes to, and use of current care guidelines among Finnish primary health care physicians). Finnish Medical Journal. 2007;62: 3319–23.
  • Finnish Statistics on Medicines. Helsinki: National Agency for Medicines and Social Insurance Institution; 1995–2008. ISSN 0786-2180.
  • Official Statistics of Finland. Tobacco Statistics 2009. ISSN = 1796-0479. Helsinki: Statistics of Finland (accessed 17 Feb 2011).
  • Okuyemi KS, Harris KJ, Scheibmeir M, Choi WS, Powell J, Ahluwalia JS. Light smokers: issues and recommendations. Nicotine Tob Res. 2002;4(Suppl 2):S103–12.
  • Hukkinen M, Kaprio J, Broms U, Koskenvuo M, Korhonen T. Characteristics and consistency of light smoking: Long-term follow-up among Finnish adults. Nicotine Tob Res. 2009;11:797–805.
  • Shiffman S, Kassel JD, Paty J, Gnys M, Zettler-Segal M. Smoking typology profiles of chippers and regular smokers. J Subst Abuse. 1994;6:21–35.
  • Hukkinen M, Korhonen T, Broms U, Koskenvuo M, Kaprio J. Long-term smoking behavior patterns predicting self-reported chronic bronchitis. COPD. 2009;6:242–9.
  • Kujala UM, Kaprio J, Koskenvuo M. Modifiable risk factors as predictors of all-cause mortality: the roles of genetics and childhood environment. Am J Epidemiol. 2002;156: 985–93.
  • British Medical Research Council; Medical Research Council's Committee on the aetiology of chronic bronchitis. Standardised questionnaires on respiratory symptoms. British Medical Journal. 1960;ii:1665.
  • Laitinen LA, Koskela K. Chronic bronchitis and chronic obstructive pulmonary disease: Finnish National Guidelines for Prevention and Treatment 1998–2007. Respir Med. 1999;93:297–332.
  • Finland's Social Insurance Institution's decisions on medical conditions for specially reimbursed medications (in Finnish). Updated 6 Sep 2010. Available at: http://www.kela.fi/in/internet/suomi.nsf/NET/270308131720KA?OpenDocument.Accessed 11 May 2011.
  • Martikainen J, Rajaniemi S. Drug reimbursement systems in EU Member States, Iceland and Norway. 2002. Available at: http://helda.helsinki.fi/bitstream/handle/10138/13932/Drug_reimbursement.pdf?sequence=1. Accessed 11 May 2011.
  • The Social Insurance Institution of Finland: Guide to benefits. 2010. Available at: http://www.kela.fi/in/internet/liite.nsf/NET/180808091909HS/$File/Pahkina_eng.pdf?Open Element. Accessed 11 May 2011.
  • StataCorp. Stata Statistical Software: Release 11. College Station, TX: StataCorp LP.; 2009.
  • Williams RL. A note on robust variance estimation for cluster-correlated data. Biometrics. 2000;56:645–6.
  • Amigo H, Oyarzun MG, Bustos P, Rona RJ. Respiratory consequences of light and moderate smoking in young adults in Chile. Int J Tuberc Lung Dis. 2006;10:744–9.
  • Vartiainen E, Seppälä T, Lillsunde P, Puska P. Validation of self-reported smoking by serume cotinine measurement in a community-based study. J Epidemiol Community Health. 2002;56:167–70.
  • Ikäheimo P, Hartikainen S, Tuuponen T, Kiuttu J, Klaukka T. Comorbidity and medication load in adult asthmatics. Scand J Prim Health Care. 2005;23: 88–94.
  • Gibson PG, Simpson JL. The overlap syndrome of asthma and COPD: what are its features and how important is it? Thorax. 2009;64:728–35.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.